Publication | Closed Access
Lithium As a Prophylactic Agent
574
Citations
7
References
1967
Year
Psychotropic MedicationPharmacotherapyMental HealthPsychologySocial SciencesClinical PsychologySpecific Therapeutic EffectUnpredictable CoursePsychoactive DrugPsychiatric DiseasePsychiatryDepressionManicdepressive PsychosisClinical PsychiatryPsychiatric DisorderMood SpectrumSide EffectClinical DisordersProphylactic AgentSchizophreniaMood DisordersMedicinePsychopathologyBipolar Disorder
THE SPECIFIC therapeutic effect of lithium in manic phases of the manicdepressive psychosis was first observed in 1949<sup>1</sup>and was confirmed later in controlled studies,<sup>2,3</sup>as well as in a number of uncontrolled ones. A prophylactic action of the drug against both the manic and depressive phases of the illness could be noted in a few of the patients described by Schou et al.<sup>2</sup>More systematic and detailed observations of this effect were made independently by Hartigan<sup>4</sup>and Baastrup,<sup>5</sup>and the term<i>normothymotics</i>was proposed for drugs with a specific action against manic-depressive psychosis.<sup>6</sup> In order to demonstrate prophylactic drug action in a disorder such as manicdepressive psychosis, which is characterized by a capricious and largely unpredictable course, one must study a large number of patients who have a sufficiently high risk of relapse and who are observed for
| Year | Citations | |
|---|---|---|
Page 1
Page 1